Dr. Adam Christopher Walchak, MD

Dr. Walchak practices at Temple Health - Chestnut Hill Hospital in Philadelphia, Pennsylvania, part of Temple University.

Dr. Walchak's NPI, 1972837730, was assigned on September 28, 2009. Dr. Walchak holds Pennsylvania license MD451887.

Dr. Walchak's primary practice is Temple Health - Chestnut Hill Hospital, at 8835 Germantown Avenue, Philadelphia, PA 19118 in Philadelphia County. The practice phone is (215) 248-8200.

Dr. Walchak's primary practice is Temple Health - Chestnut Hill Hospital in Philadelphia, Pennsylvania, part of Temple University. Dr. Walchak is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Walchak to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Walchak practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Walchak's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Walchak is licensed in Pennsylvania.

CMS data shows 95 Medicare services from Dr. Walchak across 5 procedure codes in 2024, for 89 Medicare patients. Medicare paid $4,558 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Dr. Walchak in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Walchak's median patient age at 67, with 74% women.

In 2021, Dr. Walchak wrote 82 Medicare Part D claims. They cover 3 drugs, with $693 in total drug cost. In 2020, CMS named 80 claims across 4 drugs.

Dr. Walchak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 35 procedures of mastectomy by Dr. Walchak, more than 89% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Walchak, published from 2022 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Length of Stay and Postoperative Complications. Dr. Walchak has published most often in Clin Orthop Relat Res. Dr. Walchak's most frequent co-authors are Paulette Cutruzzula Dreher, DO, Barak Marshall, DO and Samir N. Parikh, MD.

CMS Open Payments shows 122 general payments to Dr. Walchak from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. AxoGen paid the most, $3,777.